Skip to main content
Year archive

GlaxoSmithkline Pharmaceuticals Ltd. — 2022 filings

All 148 regulatory filings released by GlaxoSmithkline Pharmaceuticals Ltd. (GLAXO) in 2022, sourced directly from the official regulator.

148 Filings
2022 Period
2022 filings (148)
Filing Released Lang
Trading Window
Regulatory Filings
2022-12-29 English
Closure of Trading window
Regulatory Filings
2022-12-29 English
Loss of share certificate
Regulatory Filings
2022-12-15 English
Advance intimation under regulation 39(3) as SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings
2022-12-15 English
Loss of share certificate
Regulatory Filings
2022-12-13 English
Advance intimation under regulation 39(3) as SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings
2022-12-13 English
General updates
Regulatory Filings
2022-12-13 English
Disclosure under Regulation 30(5) of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015
Regulatory Filings
2022-12-13 English
Postal Ballot
Regulatory Filings
2022-11-30 English
Outcome of Postal Ballot Notice
Regulatory Filings
2022-11-30 English
Loss of share certificate
Regulatory Filings
2022-11-28 English
Advance intimation under regulation 39(3) as SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings
2022-11-28 English
Related Party Transaction
Regulatory Filings
2022-11-22 English
In Compliance with Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements Regulations, 2015, we enclose disclosure of Related Party Transactions for the half year ended September .
Regulatory Filings
2022-11-22 English
Loss of share certificate
Regulatory Filings
2022-11-18 English
Advance intimation under regulation 39(3) as SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings
2022-11-18 English
Newspaper Advertisements
Regulatory Filings
2022-11-15 English
Advertisement relating Results
Regulatory Filings
2022-11-15 English
Press Release
Regulatory Filings
2022-11-11 English
Media release: Q2 of 2022-23
Regulatory Filings
2022-11-11 English
Loss of share certificate
Regulatory Filings
2022-11-11 English
Outcome of Board Meeting
Regulatory Filings
2022-11-11 English
Advance intimation under regulation 39(3) as SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings
2022-11-11 English
Outcome of Board Meeting
Regulatory Filings
2022-11-11 English
Outcome of Board Meeting
Regulatory Filings
2022-11-11 English
Loss of share certificate
Regulatory Filings
2022-11-10 English
Advance intimation under regulation 39(3) as SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings
2022-11-10 English
Loss of share certificate
Regulatory Filings
2022-11-02 English
Newspaper Advertisements
Regulatory Filings
2022-11-02 English
Advertisement relating Postal Ballot Notice
Regulatory Filings
2022-11-02 English
Advance intimation under regulation 39(3) as SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings
2022-11-02 English
Board Meeting — Financial results
Regulatory Filings
2022-10-31 English
GLAXOSMITHKLINE PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2022 ,inter alia, to consider and approve Un- Audited ....
Regulatory Filings
2022-10-31 English
Postal Ballot
Regulatory Filings
2022-10-29 English
Loss of share certificate
Regulatory Filings
2022-10-29 English
Postal Ballot Notice
Regulatory Filings
2022-10-29 English
Advance intimation under regulation 39(3) as SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings
2022-10-29 English
Loss of share certificate
Regulatory Filings
2022-10-27 English
Advance intimation under regulation 39(3) as SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings
2022-10-27 English
Loss of Share Certificate
Regulatory Filings
2022-10-19 English
Loss of share certificate
Regulatory Filings
2022-10-19 English
Outcome of Board Meeting
Regulatory Filings
2022-10-17 English
Change in Directorate
Regulatory Filings
2022-10-17 English
Outcome of Meeting
Regulatory Filings
2022-10-17 English
General updates
Regulatory Filings
2022-10-10 English
Certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30th September 2022.
Regulatory Filings
2022-10-10 English
Closure of trading window
Regulatory Filings
2022-09-29 English
We wish to inform you that the in terms of the provisions of SEBI (Prohibition of Insider Trading) Regulations 2015, the trading period for buying or selling of Company's shares is closed ....
Regulatory Filings
2022-09-29 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Life Insurance Corporation of India
Regulatory Filings
2022-09-14 English
Transcript of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings
2022-08-27 English
Transcript of Analyst / Institutional Investor Meetings
Regulatory Filings
2022-08-27 English
Link for Audio Recording of Analyst Meet
Regulatory Filings
2022-08-24 English
Recording of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings
2022-08-24 English
Investor Presentation
Regulatory Filings
2022-08-24 English
Analyst Meet - Presentation
Regulatory Filings
2022-08-24 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings
2022-08-22 English
Intimation of Schedule of Analyst/ Institutional Investor Meetings under the Listing Regulations
Regulatory Filings
2022-08-22 English
BRSR Report for year ended March 2022
Regulatory Filings
2022-08-08 English
Newspaper Advertisements
Regulatory Filings
2022-07-27 English
Advertisement relating to Results
Regulatory Filings
2022-07-27 English
Annual General Meeting
Regulatory Filings
2022-07-26 English
Outcome of AGM
Regulatory Filings
2022-07-26 English
Media release: Q1 of 2022-23
Regulatory Filings
2022-07-25 English
Press Release
Regulatory Filings
2022-07-25 English
Resignation
Regulatory Filings
2022-07-25 English
Outcome of Board Meeting
Regulatory Filings
2022-07-25 English
Change in Directorate
Regulatory Filings
2022-07-25 English
Unaudited (Standalone and Consolidated) financial results for the first quarter ended 30th June 2022
Regulatory Filings
2022-07-25 English
Unaudited (Standalone and Consolidated) financial results for the first quarter ended 30th June 2022
Regulatory Filings
2022-07-25 English
Certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30th June 2022.
Regulatory Filings
2022-07-06 English
General updates
Regulatory Filings
2022-07-06 English
Closure of trading window
Regulatory Filings
2022-06-28 English
Board Meeting — Financial results
Regulatory Filings
2022-06-28 English
Closure of Trading Window
Regulatory Filings
2022-06-28 English
GLAXOSMITHKLINE PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/07/2022 ,inter alia, to consider and approve Un- Audited ....
Regulatory Filings
2022-06-28 English
General updates
Regulatory Filings
2022-06-27 English
Newspaper Advertisements
Regulatory Filings
2022-06-27 English
Notice to shareholders of the Company holding shares in physical form with regard to norms for furnishing PAN, KYC details and Nomination
Regulatory Filings
2022-06-27 English
Publication of AGM & Evoting Add
Regulatory Filings
2022-06-27 English
Annual Report for financial year ended 31st March 2022
Regulatory Filings
2022-06-24 English
Change in Directorate
Regulatory Filings
2022-06-16 English
Resignation
Regulatory Filings
2022-06-16 English
New paper publication
Regulatory Filings
2022-06-15 English
Newspaper Advertisements
Regulatory Filings
2022-06-15 English
Newspaper Advertisements
Regulatory Filings
2022-06-13 English
Add relating to IEPF Notice
Regulatory Filings
2022-06-13 English
The Board has recommended a dividend of Rs. 90/- (including special dividend of Rs. 60) per equity share on face value of Rs.10 each for the year ended 31 st March 2022, subject to approval ....
Regulatory Filings
2022-06-10 English
Record Date
Regulatory Filings
2022-06-10 English
Related Party Transaction
Regulatory Filings
2022-05-30 English
Submission of Disclosure on Related Party Transactions
Regulatory Filings
2022-05-30 English
Loss of share certificate
Regulatory Filings
2022-05-20 English
Advance intimation under regulation 39(3) as SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings
2022-05-20 English
Newspaper Advertisements
Regulatory Filings
2022-05-18 English
Advt relating Financial Results
Regulatory Filings
2022-05-18 English
Annual Secretarial Compliance Report for the financial year ended March 31,2022
Regulatory Filings
2022-05-17 English
Press Release
Regulatory Filings
2022-05-16 English
Media release: Q4 & FY21-22
Regulatory Filings
2022-05-16 English
Annual General Meeting
Regulatory Filings
2022-05-16 English
outcome of meeting
Regulatory Filings
2022-05-16 English
Outcome of meeting
Regulatory Filings
2022-05-16 English
Financial Result Updates
Regulatory Filings
2022-05-16 English
outcome of meeting
Regulatory Filings
2022-05-16 English
Re-appointment
Regulatory Filings
2022-05-16 English
Appointment
Regulatory Filings
2022-05-16 English
Dividend
Regulatory Filings
2022-05-16 English
Dividend
Regulatory Filings
2022-05-16 English
Outcome of Board Meeting
Regulatory Filings
2022-05-16 English
Outcome of Meeting
Regulatory Filings
2022-05-16 English
outcome of meeting
Regulatory Filings
2022-05-16 English
outcome of meeting
Regulatory Filings
2022-05-16 English
outcome of meeting
Regulatory Filings
2022-05-16 English
Board Meeting — Dividend/Financial results
Regulatory Filings
2022-05-02 English
GlaxoSmithKline Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors of the Company will be heldon May 16, 2022, to consider amongst other things, approval ....
Regulatory Filings
2022-05-02 English
GLAXOSMITHKLINE PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/05/2022 ,inter alia, to consider and approve Pursuant to ....
Regulatory Filings
2022-05-02 English
Postal Ballot
Regulatory Filings
2022-04-21 English
Outcome of Postal Ballot
Regulatory Filings
2022-04-21 English
As required under Clause 40(9) of the Listing Obligations and Disclosure RequirementsRegulations, 2015 (LODR), we are enclosing herewith copy of the certificate issued by Manish Ghia & ....
Regulatory Filings
2022-04-13 English
General updates
Regulatory Filings
2022-04-11 English
In terms of Regulation 30(5) of the SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015, the Board of Directors have jointly authorized the following personnel of the Company, ....
Regulatory Filings
2022-04-11 English
General updates
Regulatory Filings
2022-04-07 English
We would like to inform that the name of the Registrar and Transfer Agent of the Company has been changed from ''Kfin Technologies Private Limited'' to ''Kfin Technologies Limited'' with ....
Regulatory Filings
2022-04-07 English
General updates
Regulatory Filings
2022-04-06 English
General updates
Regulatory Filings
2022-04-06 English
With reference to above circular, we would like to inform you that our Company - GlaxoSmithKline Pharmaceuticals Limited is not a Large Corporate (LC) as per the framework provided in the ....
Regulatory Filings
2022-04-06 English
Compliance of Clause 7 (3) for year ended 31st March 2022
Regulatory Filings
2022-04-06 English
Certificate pursuant to Regulation 74(5)
Regulatory Filings
2022-04-06 English
Annual Disclosure
Regulatory Filings
2022-04-05 English
Closure of trading window
Regulatory Filings
2022-03-31 English
Closure of Trading Window
Regulatory Filings
2022-03-31 English
Newspaper Advertisements
Regulatory Filings
2022-03-24 English
Pursuant to clause 47 of the Listing Obligations and Disclosure Requirements Regulations, 2015 (LODR) we enclose advertisements given in Economic Times, Business Standard and Maharashtra ....
Regulatory Filings
2022-03-24 English
Postal Ballot
Regulatory Filings
2022-03-22 English
Postal Ballot Notice
Regulatory Filings
2022-03-22 English
Sale or disposal of unit/ division/subsidiary
Regulatory Filings
2022-03-16 English
Completion of Sale of Company''s trademarks ''pertaining to ''lodex'' and ''Ostocalcium'' Brands in India
Regulatory Filings
2022-03-16 English
Copy of Newspaper Publication
Regulatory Filings
2022-02-15 English
Advertisement relating Results
Regulatory Filings
2022-02-15 English
Change in Director(s)
Regulatory Filings
2022-02-07 English
Change in Directorate
Regulatory Filings
2022-02-07 English
Please find enclosed a press release issued by the Company in respect of financial results for the quarter ended 31st December 2021
Regulatory Filings
2022-02-07 English
Press Release
Regulatory Filings
2022-02-07 English
Outcome of Board Meeting
Regulatory Filings
2022-02-07 English
Financial Result Updates
Regulatory Filings
2022-02-07 English
Unaudited (Standalone and Consolidated) financial results for the third quarter and nine months ended 31st December 2021
Regulatory Filings
2022-02-07 English
Unaudited (Standalone and Consolidated) financial results for the third quarter and nine months ended 31st December 2021
Regulatory Filings
2022-02-07 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings
2022-01-10 English
Updates
Regulatory Filings
2022-01-10 English
Certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 31st December 2021
Regulatory Filings
2022-01-10 English